Influence of nucleoside analogue treatment on telomere length and TRF2 amount in human HL60 cells. 2007

Xiaohong Liu, and Jingping Liu, and Tsukasa Ogawara, and Yuichi Kurashina, and Ryosuke Yashi, and Mineo Saneyoshi, and Toyofumi Yamaguchi
Biotechnology Research Center, Teikyo University of Science and Technology and Biosciences, Uenohara, Yamanashi, Japan.

Long-term treatment with 3'-azido-2',3'-dideoxy-guanosine (AZddG) results in reproducible telomere shortening in cultured human HL60 cells. TRF2 protein has been implicated in the protection of chromosome ends. It binds to double-strand repeats and may have an indirect role in protecting the G-rich overhang by recruiting other telomere-binding proteins to the G-tail or by mediating the formation of the telomeric t-loop. Western blot analysis demonstrated no change or a slight increase, of the TRF2 protein level in HL60 cells with AZddG-induced telomere shortening. The effects of nucleoside analogues on TRF2 suggest that it is not telomere length per se, but rather the presence or absence of a protective telomere state, which determines whether senescence ensues.

UI MeSH Term Description Entries
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D016615 Telomere A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs. Telomeres
D018922 HL-60 Cells A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. (From Hay et al., American Type Culture Collection, 7th ed, pp127-8) HL60 Cells,Cell, HL60,Cells, HL60,HL 60 Cells,HL-60 Cell,HL60 Cell
D035341 Telomeric Repeat Binding Protein 2 A ubiquitously expressed telomere-binding protein that is present at TELOMERES throughout the cell cycle. It is a suppressor of telomere elongation and may be involved in stabilization of telomere length. It is structurally different from TELOMERIC REPEAT BINDING PROTEIN 1 in that it contains basic N-terminal amino acid residues. TRF2 Protein,TERF2 Protein,TRBF2 Protein,Trf2 Gene Product,Gene Products, Trf2,Products, Trf2 Gene,Proteins, TERF2,Proteins, TRBF2,Proteins, TRF2,TERF2 Proteins,TRBF2 Proteins,TRF2 Proteins,Trf2 Gene Products

Related Publications

Xiaohong Liu, and Jingping Liu, and Tsukasa Ogawara, and Yuichi Kurashina, and Ryosuke Yashi, and Mineo Saneyoshi, and Toyofumi Yamaguchi
January 2005, Nucleic acids symposium series (2004),
Xiaohong Liu, and Jingping Liu, and Tsukasa Ogawara, and Yuichi Kurashina, and Ryosuke Yashi, and Mineo Saneyoshi, and Toyofumi Yamaguchi
March 2000, Molecular and cellular biology,
Xiaohong Liu, and Jingping Liu, and Tsukasa Ogawara, and Yuichi Kurashina, and Ryosuke Yashi, and Mineo Saneyoshi, and Toyofumi Yamaguchi
October 2008, Mechanisms of ageing and development,
Xiaohong Liu, and Jingping Liu, and Tsukasa Ogawara, and Yuichi Kurashina, and Ryosuke Yashi, and Mineo Saneyoshi, and Toyofumi Yamaguchi
October 2009, Molecular and cellular biology,
Xiaohong Liu, and Jingping Liu, and Tsukasa Ogawara, and Yuichi Kurashina, and Ryosuke Yashi, and Mineo Saneyoshi, and Toyofumi Yamaguchi
December 2001, Pharmaceutical research,
Xiaohong Liu, and Jingping Liu, and Tsukasa Ogawara, and Yuichi Kurashina, and Ryosuke Yashi, and Mineo Saneyoshi, and Toyofumi Yamaguchi
January 2004, Nucleic acids symposium series (2004),
Xiaohong Liu, and Jingping Liu, and Tsukasa Ogawara, and Yuichi Kurashina, and Ryosuke Yashi, and Mineo Saneyoshi, and Toyofumi Yamaguchi
January 2002, Radiation medicine,
Xiaohong Liu, and Jingping Liu, and Tsukasa Ogawara, and Yuichi Kurashina, and Ryosuke Yashi, and Mineo Saneyoshi, and Toyofumi Yamaguchi
January 2017, Journal of Ayurveda and integrative medicine,
Xiaohong Liu, and Jingping Liu, and Tsukasa Ogawara, and Yuichi Kurashina, and Ryosuke Yashi, and Mineo Saneyoshi, and Toyofumi Yamaguchi
January 2003, Stem cells (Dayton, Ohio),
Xiaohong Liu, and Jingping Liu, and Tsukasa Ogawara, and Yuichi Kurashina, and Ryosuke Yashi, and Mineo Saneyoshi, and Toyofumi Yamaguchi
October 2012, Nucleic acids research,
Copied contents to your clipboard!